Galactosylated streptavidin for improved clearance of biotinylated intact and F(ab')2 fragments of an anti-tumour antibody.

Documenti analoghi

• Polyethylene glycol modification of a galactosylated streptavidin clearing agent: effects on immunogenicity and clearance of a biotinylated anti-tumour antibody.
  di: Marshall, D., et al.
  Pubblicazione: (1996)
• Comparative radioimmunotherapy using intact or F(ab')2 fragments of 131I anti-CEA antibody in a colonic xenograft model.
  di: Pedley, R. B., et al.
  Pubblicazione: (1993)
• Clearance of circulating radio-antibodies using streptavidin or second antibodies in a xenograft model.
  di: Marshall, D., et al.
  Pubblicazione: (1994)
• Dose-dependent localisation and potential for therapy of F(ab')2 fragments against CEA studied in a human tumour xenograft model.
  di: Rogers, G. T., et al.
  Pubblicazione: (1986)
• Clearance of yttrium-90-labelled anti-tumour antibodies with antibodies raised against the 12N4 DOTA macrocycle.
  di: Casey, J. L., et al.
  Pubblicazione: (1998)